Emergent BioSolutions Inc...

NYSE: EBS · Real-Time Price · USD
8.85
0.03 (0.34%)
At close: Aug 15, 2025, 3:59 PM
8.82
-0.28%
After-hours: Aug 15, 2025, 07:40 PM EDT

Emergent BioSolutions Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Net Income
139.5M -131.6M -190.6M -208.8M -587M -565.2M -757.2M -795.7M -608M -403.1M -223.8M 53.5M 96.5M 157.5M 230.9M 227M 299.2M 387.3M
Depreciation & Amortization
101.3M 107.2M 110.6M 115.1M 117.8M 121.3M 127.1M 132.2M 135.4M 147M 143.3M 136.9M 137.3M 126M 123.8M 123.5M 119.6M 115M
Stock-Based Compensation
12.7M 13.6M 18M 17.7M 19.4M 22.2M 23.1M 30.8M 38M 42M 45.1M 43.5M 42.7M 41.8M 42.4M 42.3M 41.9M 54.9M
Other Working Capital
-22.5M 173.4M 170.6M 170.7M 133.9M -60.5M -59.9M 29.4M 26.8M 19M -48.3M -85.7M -96.5M -99M -61.7M -29.6M -89.4M -18.2M
Other Non-Cash Items
42.3M 82.4M 212.2M 211.2M 492.5M 600.9M 479.9M 475.4M 269.3M 20.5M 19.8M -44.9M 33.8M 30M 33.5M 92.6M 61M 63.3M
Deferred Income Tax
11.6M 25.3M -5.5M -10.3M -11.1M -12.7M -8.9M -45.7M -31.8M -29.3M -19M 69.3M 52.7M 50.5M 46.9M 2.6M -1.9M 100K
Change in Working Capital
-138.4M 67.5M 88.7M 220.5M 220.1M -131M -70.3M 57.4M -82.5M 42.1M 500K -56.2M -70.2M -127.1M -156.4M -250.8M -194.1M -137.3M
Operating Cash Flow
169M 110.1M 58.7M 170.7M 77M -84.9M -206.3M -145.6M -279.6M -180.8M -34.1M 202.1M 292.8M 278.7M 321.1M 237.2M 325.7M 483.3M
Capital Expenditures
-14M -15.7M -22.9M -32.6M -39.4M -47.3M -51.6M -63.8M -79.1M -98.7M -115.8M -138.9M -166.2M -201.1M -225M -214.3M -204.8M -172.9M
Cash Acquisitions
n/a n/a n/a -270.2M -270.2M n/a n/a 270.2M 270.2M n/a n/a n/a n/a n/a n/a n/a n/a n/a
Purchase of Investments
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Sales Maturities Of Investments
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Investing Acitivies
231.3M 211.2M 148.1M 388M 263.9M 534.1M 534.1M 242.1M 4.7M -265.5M -265.5M -243.7M n/a n/a -88.6M -251.6M -251.6M -261.6M
Investing Cash Flow
217.3M 195.5M 125.2M 85.2M -45.7M 216.6M 212.3M 178.3M -74.4M -364.2M -381.3M -382.6M -166.2M -201.1M -225M -214.3M -204.8M -182.9M
Debt Repayment
-194M -245.4M -204.3M -200.2M -49.1M -493.9M -543.4M -196M 76.5M 564.3M 564.2M 204.3M -30.9M -28.2M -35.9M -33.2M 66.6M 69.5M
Common Stock Repurchased
-6.9M -200K -600K -600K -700K -500K -2.2M -2.4M -2.6M -27M -82.4M -188.5M -188.7M -165.1M -119.8M -14.5M -15.1M -20.4M
Dividend Paid
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies
5.3M 5.3M 5.3M 4.9M 400K 1M -700K 700K 500K 1.5M -900K -1.7M -800K -1M -2.5M -100K -7.8M -2.2M
Financial Cash Flow
-186.6M -231.1M -190M -185.8M -48.5M -484.5M -535.7M -187.3M 85M 541.2M 481.2M 18.1M -216.2M -189.3M -141M -33.3M 58.8M 67.3M
Net Cash Flow
200M 73.8M -6.1M 68.6M -107.3M -440.9M -620.6M -242.9M -269.7M -5.8M 66.3M -163M -89.4M -112M -45.2M -11.2M 178.7M 366.3M
Free Cash Flow
155M 94.4M 35.8M 138.1M 37.6M -132.2M -257.9M -209.4M -358.7M -279.5M -149.9M 63.2M 126.6M 77.6M 96.1M 22.9M 120.9M 310.4M